Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer/T-cell lymphoma
Maarja‐Liisa Nairismägi(National Cancer Centre Singapore), Jing Tan(Genome Institute of Singapore)
Cited by 57
Related Papers
Apoptosis Signal-regulating Kinase 1 Is a Direct Target of E2F1 and Contributes to Histone Deacetylase Inhibitorinduced Apoptosis through Positive Feedback Regulation of E2F1 Apoptotic Activity
|Journal of Biological Chemistry|2006|63
Targeting the IRAK1–S100A9 Axis Overcomes Resistance to Paclitaxel in Nasopharyngeal Carcinoma
|Cancer Research|2021|47
RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer
|Journal of Clinical Investigation|2022|43
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer
|Journal of Clinical Investigation|2021|34
Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
|Clinical Epigenetics|2023|22